Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yes me too, this is now the largest in my PF, barring a huge collaspe in US Pharma sector between now and November I think there will be at least 50% upside from here however if the market is still bullish and some of our private investments have IPO's between now and then (which I think they will) we could be looking at 100% upside with the only real risk being the whole sector crashing as the investments are now well spread with the Magna fund.
Hope to increase holding here if any of my speculative punts/investments bear fruition
I have been adding weekly for some time, a hold till Nov will reward me well.
I don't know why either
this is slipping lower and lower...
Top 10 Stocks 9 up, some well up 1 even
I think many are- my last two buys over this week showed as sales as well.
Have a look at the lasted NAV -it seems only available on the London Stock Exchange site. They still held PLE and SUMM. They , to my knowledge have not and could not, transfer share. I assume they have sold and bought units in Magne. Quite what happens when the deal at PEBI Nav goes through to the Magna holding I am unsure. I suspect they will be sold to meet likely redemptions at the NAV transfer value-about 16.5 p currently. They obvioulsy could not hold units in thier own fund.
Why do you think plethora or summit positions did not transfer to magna. The manager told me today that the fund is worth a little over $6m
Have bought a few more today. showing as a sell
This is almost to good to be true. I have spoken to the promoters of the fund-they thought deal was done. Seems they were unaware you could buy into Magna fund at a 40% discount through PEBI. If I was them I would be getting people to buy PEBI as a cheap way in. I have never in my years in the 1980's as a broker in investment Trust sector seen a share trade at such a discount to the potential Unitisation price. Having looked at the portfolio of Magna looks pretty sound if you want to be in the fast growing Biopharmacy area. I can only assume PEBI is so small not on the radar. Bought more to-day and will continue-not often have a gift like this. Though my purchase did show as a sale-the prices shown are not always the dealing price and got more to-day well below what offer was shown as.
Yes we are getting cheap Magna shares 40% discount ssssshhhhhhh :)
There was a very nice 243k buy towards the end of today, and it bodes well
AbbVie USA.Pharmaceuticals AmpliPhi Biosciences USA Biotechnology Arrowhead USA Biotechnology Gilead USA Biotechnology GlaxoSmithKline UK Pharmaceuticals Johnson & Johnson USA Pharmaceuticals Merck USA Pharmaceuticals Pfizer USA Pharmaceuticals Roche Switzerland Pharmaceuticals Sanofi France Pharmaceuticals In alphabetical order Combined weight of top 10 holdings: 53
With arrowhead now at $14 and Medivation at $85 this stock is looking very attractive. Shame about share price.
That is my understanding-NAV in Nov. Hence bought yet more-either I have lost the plot, or we are able to buy into Magna at a Huge discount. I am getting a fact sheet re Magna at the end of this week.
Hi yes its a secretive fund! Hope the link below helps, so now that 55% of PEBI is in the Magna fund is that at NAV value in the fund i.e. if we were now in November would we be able to take out of Magna at NAV value? http://www.bloomberg.com/quote/MBIBAAE:ID
All very odd. Have you found where the Magna Unit price is-I have tried(rather half-heartedly I admit). As they have moved funds into the fund, it should secure the NAV-well will be easy to monitor as normally a Fund NAV is updated daily. As I see it the Magna fund is marketed in a closed fashion. I assume this will change post acquisition. These could be the question behind the sales-how and where can the future units be traded. If answered I tell you if I was still in the 1980's when ran a small Investment Company I would be pouring money in-40% discount to NAV paid in 9 months-no brainer! For some reason Asset funds have fallen out of flavour last few weeks seen massive sells in another fund MPO-which I again cannot understand.
2 big buys and the price drops (again) wish I had loaded up now and not at 13p and 12p ! The NAV is all that matters 15.9p at last count.
Yes well done on your profit so far, I was well in profit when the bid touched 15p ish recently but holding all until at least Nov, this is definitely a share for the low risk investor with patience. I think the £350k with unlisted companies may give us at least 1 or 2 IPO's this year and the £800k uninvested could well be added to Magna IMO.
Agree.You have done well to contact the Company. I have failed but have based my buy's on discount to good growth assets.
I actualky thought it sounded too good to be true but after conversations and emails with the company I fully understand and see the upside and how it will play out. Knowing the AIM market well and how 'the herd' work I expected the closer to Nov this year the closer to NAV to sp will get. I actually have a 25p target for Nov which gives 100% upside from a 11.5p buy, if SUMM or PLE continue to rise, reach previous highs or one/both get bought out well 40p could be the NAV. I find it very interesting that Jim Mellon is on the BOD and has left these 2 shares in and at a high% of PEBI !!! As PEBI was set out to 'mirror Jim Mellons investments and demonstrate the huge returns in the Bio Pharma sector I think many people (probably including me) will say in Nov 'why didn't I buy more at 11.25p ! This ISN'T a miner needing money, a O&G share risking a duster, a Tech share risking a 'newcomer' or a early stage high risk Pharma share but one offering a 40% discount to buy shares in large American Pharma's and well researched growth stocks picked by a man with a net worth of £700m - Strong buy from me.
I am very happy to have bought my original stake back. Done OK with this investment since I purchased and sold half at the peak. Cannot understand the discount to NAV with Unitisation at NAV coming soon.As said before I used to deal in Investment Trusts and given news in my day's would be trading at 5% discount max. I am very happy to see a further 40% return on current discount to NAV=best performer I have held this year-total return at the NAV is 140%, way above my investment target of 10% per annum for Pension fund. Will look at SKIL, but currently looking at Coffee Plantations-coffee price is low at moment. If I can find a quoted PLC in UK.
Oldstock - The shares are very similar and most of the good performing ones such as Arrowhead are a good % of the fund, they have gone for shares which pay good dividends too, I actually think having 55% of PEBI in Magna is actually lower risk as there seems more bias towards big, profitable, divi paying companies in the sector. There is still a exciting element to more risky high reward stocks too but circa 30%, the Magna fund covers many more shares than PEBI ever has - well over 30 which means less risk too. I have rung PEBI and the fund holders to find out all I can but until it is up and live on Hargreaves Lansdown and others information is very limited. The newsletter apparently will be out soon at Charlemagne so maybe email or ring them regarding that. At the end of the day if you believe in the Bio Pharma sector especially in the US and Jim Mellon (net worth £700m) this is a great way to mirror his investment ideas, strategy and a small % of his wealth growth !!!!!! Shareminator - Thanks for the Bloomberg link thats great.